Scott M. Whitcup, M.D.
Scott Whitcup, M.D. joined Adverum’s Board in April 2020. Dr. Scott Whitcup is the founder and chief executive officer of Akrivista and Whitecap Biosciences, two companies focused on developing new therapies in ophthalmology and dermatology. Previously, Dr. Whitcup was the executive vice president, R&D and chief scientific officer at Allergan where he led the discovery, clinical development, and medical affairs organizations focused on therapeutic areas including ophthalmology, CNS, urology, dermatology, and medical aesthetics. Before Allergan, Dr. Whitcup was the clinical director at the National Eye Institute at NIH. Dr. Whitcup received a BA from Cornell University and an MD from Cornell University Medical College. He completed an internal medicine residency at UCLA and an ophthalmology residency at Harvard University at the Massachusetts Eye and Ear Infirmary. He is an inventor on over 25 issued patents in the US and an author on over 200 scientific articles and books. Dr. Whitcup is currently on the Clinical Faculty at the UCLA Stein Eye Institute and serves on the board of directors of Scilex Pharmaceuticals and Anivive Lifesciences.